CONMED Corporation announced the addition of Kim Kelderman to its Board of Directors.
Kim Kelderman brings extensive global leadership experience in life sciences businesses.
His skills and insights will be valuable additions to the board.
New Board Member
Kim Kelderman, President and CEO of Bio-Techne, joins CONMED's Board of Directors.
Experience and Expertise
Kelderman's background at Bio-Techne and Thermo Fisher Scientific highlights his leadership in the healthcare industry.
Innovative Perspective
The appointment of Kelderman reflects CONMED's focus on innovation and strategy in its governance.
- Kim Kelderman's appointment demonstrates CONMED's commitment to enhancing its board's expertise and diversity.
- His experience in medical technology and global business operations will contribute to CONMED's strategic decision-making.
The addition of Kim Kelderman to CONMED's Board of Directors is expected to bring a fresh perspective and valuable insights to the company's strategic direction and governance.